A390110 Stock Overview
Anymedi Inc. produces and sells medical solutions for surgeons and patients.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Anymedi Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩1,258.00 |
| 52 Week High | ₩8,460.00 |
| 52 Week Low | ₩1,016.00 |
| Beta | 0 |
| 1 Month Change | -15.51% |
| 3 Month Change | -39.23% |
| 1 Year Change | -77.62% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -86.33% |
Recent News & Updates
Recent updates
Shareholder Returns
| A390110 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | -5.4% | 7.6% | 3.4% |
| 1Y | -77.6% | 33.4% | 7.1% |
Return vs Industry: A390110 underperformed the KR Medical Equipment industry which returned 33.4% over the past year.
Return vs Market: A390110 underperformed the KR Market which returned 7.1% over the past year.
Price Volatility
| A390110 volatility | |
|---|---|
| A390110 Average Weekly Movement | 14.5% |
| Medical Equipment Industry Average Movement | 6.3% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 11.8% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A390110's share price has been volatile over the past 3 months.
Volatility Over Time: A390110's weekly volatility has decreased from 20% to 15% over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | n/a | n/a | anymedi.com |
Anymedi Inc. produces and sells medical solutions for surgeons and patients. It offers simulators, surgical guides, and implants. The company was founded in 2006 and is headquartered in Seoul, South Korea.
Anymedi Inc. Fundamentals Summary
| A390110 fundamental statistics | |
|---|---|
| Market cap | ₩11.29b |
| Earnings (TTM) | ₩0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs A390110 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A390110 income statement (TTM) | |
|---|---|
| Revenue | ₩0 |
| Cost of Revenue | ₩0 |
| Gross Profit | ₩0 |
| Other Expenses | ₩0 |
| Earnings | ₩0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did A390110 perform over the long term?
See historical performance and comparison